Gazyva (obinutuzumab)
pCPA File Number:
23593
Negotiation Status:
Under consideration for negotiation
Indication(s):
Active lupus nephritis
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
SR0891-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable